These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11320187)

  • 21. Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation.
    Jeppesen TD; Schwartz M; Frederiksen AL; Wibrand F; Olsen DB; Vissing J
    Arch Neurol; 2006 Dec; 63(12):1701-6. PubMed ID: 17172609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients harboring the A3243G point mutation or large-scale deletions of mitochondrial DNA.
    Vielhaber S; Varlamov DA; Kudina TA; Schröder R; Kappes-Horn K; Elger CE; Seibel M; Seibel P; Kunz WS
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):885-95. PubMed ID: 12387454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Manifestations of the mitochondrial A3243G mutation.
    Finsterer J
    Int J Cardiol; 2009 Sep; 137(1):60-2. PubMed ID: 18662836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies.
    Filosto M; Mancuso M; Vives-Bauza C; Vilà MR; Shanske S; Hirano M; Andreu AL; DiMauro S
    Ann Neurol; 2003 Oct; 54(4):524-6. PubMed ID: 14520667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of MELAS and its relation with A3243G gene point mutation.
    Zhang J; Guo J; Fang W; Jun Q; Shi K
    Int J Clin Exp Pathol; 2015; 8(10):13411-5. PubMed ID: 26722549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical heterogeneity associated with mitochondrial DNA depletion in muscle.
    Campos Y; Martín MA; García-Silva T; del Hoyo P; Rubio JC; Castro-Gago M; García-Peñas J; Casas J; Cabello A; Ricoy JR; Arenas J
    Neuromuscul Disord; 1998 Dec; 8(8):568-73. PubMed ID: 10093063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial myopathies.
    Larsson NG; Oldfors A
    Acta Physiol Scand; 2001 Mar; 171(3):385-93. PubMed ID: 11412152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cultured myoblasts: a model for the diagnosis of mitochondrial diseases.
    Dumoulin R; Mandon G; Collombet JM; Blond JL; Carrier H; Godinot C; Flocard F; Villard J; Guibaud P; Mathieu M
    J Inherit Metab Dis; 1993; 16(3):545-7. PubMed ID: 7609448
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and genetic features in two families with MELAS and the T3271C mutation in mitochondrial DNA.
    Tay SK; Shanske S; Crowe C; Shanske A; Schafer I; Pancrudo J; Lu J; Bonilla E; DiMauro S
    J Child Neurol; 2005 Feb; 20(2):142-6. PubMed ID: 15794182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation.
    Auré K; Fayet G; Leroy JP; Lacène E; Romero NB; Lombès A
    Brain; 2006 May; 129(Pt 5):1249-59. PubMed ID: 16537564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal muscle gene expression profiling in mitochondrial disorders.
    Crimi M; Bordoni A; Menozzi G; Riva L; Fortunato F; Galbiati S; Del Bo R; Pozzoli U; Bresolin N; Comi GP
    FASEB J; 2005 May; 19(7):866-8. PubMed ID: 15728662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of maternal A3243G mtDNA mutation and reversible hyperglycemia in a patient with MELAS syndrome.
    Liou CW; Huang CC; Tsai JL; Liu JY; Pang CY; Lee HC; Wang EK; Wei YH
    Acta Neurol Scand; 2000 Jan; 101(1):65-9. PubMed ID: 10660156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Audiologic features of mitochondrial DNA A3243G mutation and its correlation with mutation rate].
    Xue JF; Chen L; Ma YN; Zhao DH; Duan JB; Wang ZX; Qi Y; Liu YH
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2830-4. PubMed ID: 23290211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of A3243G point mutation in mitochondrial DNA from 10 cases of MELAS.
    Wang Z; Liu S; Yang Y; Yuan Y; Wu L; Qi Y; Chen Q
    Chin Med J (Engl); 2002 Jul; 115(7):995-7. PubMed ID: 12150728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heteroplasmic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells.
    Lynn S; Borthwick GM; Charnley RM; Walker M; Turnbull DM
    Diabetologia; 2003 Feb; 46(2):296-9. PubMed ID: 12627331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical phenotype, prognosis and mitochondrial DNA mutation load in mitochondrial encephalomyopathies.
    Huang CC; Kuo HC; Chu CC; Liou CW; Ma YS; Wei YH
    J Biomed Sci; 2002; 9(6 Pt 1):527-33. PubMed ID: 12372990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New genetics of mitochondrial DNA diseases.
    Poulton J
    Br J Hosp Med; 1996 Jun 5-18; 55(11):712-6. PubMed ID: 8793140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation.
    Barbiroli B; Montagna P; Cortelli P; Iotti S; Lodi R; Barboni P; Monari L; Lugaresi E; Frassineti C; Zaniol P
    Neurology; 1995 Jul; 45(7):1364-9. PubMed ID: 7617199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation.
    Tarnopolsky MA; Simon DK; Roy BD; Chorneyko K; Lowther SA; Johns DR; Sandhu JK; Li Y; Sikorska M
    Muscle Nerve; 2004 Apr; 29(4):537-47. PubMed ID: 15052619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy.
    Jeppesen TD; Schwartz M; Olsen DB; Vissing J
    Ann Neurol; 2003 Jul; 54(1):86-92. PubMed ID: 12838523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.